Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD
Conditions:   Meibomian Gland Dysfunction;   Blepharitis;   Demodex Infestation Interventions:   Drug: TP-03;   Drug: TP-03 Vehicle Sponsor:   Tarsus Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2022 Category: Research Source Type: clinical trials

Treatment of Blepharitis With Povidone-Iodine 1%
Condition:   Anterior Blepharitis Interventions:   Drug: Povidone-Iodine 1 % Topical Solution;   Drug: Eyelid cleansing wipes Sponsor:   Shaare Zedek Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2021 Category: Research Source Type: clinical trials